The following abstracts and posters were curated from all the posters presented at the American College of Rheumatology Annual Meeting held November 14-19, 2014, in Boston, Massachusetts. The central theme of these posters is long-term drug safety. Specifically, the posters we selected highlight the long-term incidence of adverse events and serious infections among patients with rheumatoid arthritis treated with biologic agents and disease-modifying antirheumatic drugs.  

Faculty

Rheumatologist Alvin F. Wells, MD, PhD, director of the Rheumatology and Immunotherapy Center in Franklin, Wisconsin, and assistant professor at Duke University Medical Center,  in Durham , North Carolina provides his perspective on key rheumatoid arthritis posters from the 2014 American College of Rheumatology Annual Meeting held November 14-19, in Boston, Massachusetts.

Target audience

Rheumatology, Internal Medicine, Family Medicine, Other Physician, Physician Assistant, Nurse Practitioner, Other HCP

Instructions

You may participate by listening to any—or all—of the audio discussions. Click the ‘Play’ button to hear our faculty review the data and clinical implications of each poster/abstract. Two questions will appear at the end of discussion. When ready to claim your CE/CME credit, click the Get CME Credit button.

This activity is supported by an independent educational grant from Pfizer.